# EDGAR Filing Document

**Accession Number:** 0001068875
**File Stem:** 0001839882-23-003443
**Filing Date:** 2023-2
**Character Count:** 11925
**Document Hash:** 5b76fecb9fa5eb30a60b8fb7945a2f44
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001839882-23-003443.hdr.sgml**: 20230330

**ACCESSION NUMBER**: 0001839882-23-003443

**CONFORMED SUBMISSION TYPE**: SC TO-I/A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20230209

**DATE AS OF CHANGE**: 20230209

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AVANTAX, INC.
- **CENTRAL INDEX KEY:** 0001068875
- **STANDARD INDUSTRIAL CLASSIFICATION:** FINANCE SERVICES [6199]
- **IRS NUMBER:** 911718107
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-55807
- **FILM NUMBER:** 23607266

**BUSINESS ADDRESS:**
- **STREET 1:** 3200 OLYMPUS BLVD.
- **STREET 2:** SUITE 100
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75019
- **BUSINESS PHONE:** 972-870-6000

**MAIL ADDRESS:**
- **STREET 1:** 3200 OLYMPUS BLVD.
- **STREET 2:** SUITE 100
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75019

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BLUCORA, INC.
- **DATE OF NAME CHANGE:** 20120605

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INFOSPACE INC
- **DATE OF NAME CHANGE:** 20000428

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INFOSPACE COM INC
- **DATE OF NAME CHANGE:** 19980824
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AVANTAX, INC.
- **CENTRAL INDEX KEY:** 0001068875
- **STANDARD INDUSTRIAL CLASSIFICATION:** FINANCE SERVICES [6199]
- **IRS NUMBER:** 911718107
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I/A

**BUSINESS ADDRESS:**
- **STREET 1:** 3200 OLYMPUS BLVD.
- **STREET 2:** SUITE 100
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75019
- **BUSINESS PHONE:** 972-870-6000

**MAIL ADDRESS:**
- **STREET 1:** 3200 OLYMPUS BLVD.
- **STREET 2:** SUITE 100
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75019

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BLUCORA, INC.
- **DATE OF NAME CHANGE:** 20120605

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INFOSPACE INC
- **DATE OF NAME CHANGE:** 20000428

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INFOSPACE COM INC
- **DATE OF NAME CHANGE:** 19980824

**As filed with the Securities and Exchange Commission on February 9, 2023**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE TO**

**Tender Offer Statement under Section 14(d)(1) or 13(e)(1)<br> of the Securities Exchange Act of 1934**

**(Amendment No. 2)**

**Avantax, Inc.**

**(Name of Subject Company (Issuer))**

**Avantax, Inc.**

**(Names of filing Persons (Offeror and Issuer))**

**Common Stock, par value $0.0001 per share<br> (Title of Class of Securities)<br> 095229100<br> (CUSIP Number of Class of Securities)<br> (Underlying Common Stock)**

**Tabitha Bailey<br> Chief Legal Officer and Corporate Secretary<br> Avantax, Inc.<br> 3200 Olympus Blvd, Suite 100<br> Dallas, Texas 75019<br> Tel: (972) 870-6400**

**(Name, address and telephone number of person authorized to receive notices and communications on behalf of filing person)**

***Copies to:*<br> Beth E. Berg<br> Sidley Austin LLP<br> One South Dearborn<br> Chicago, Illinois 60603<br> (312) 853-7443**

☐ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

☐ Third-party tender offer subject to Rule 14d-1.

☒ Issuer tender offer subject to Rule 13e-4.

☐ Going-private transaction subject to Rule 13e-3.

☐ Amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐

If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:

☐ Rule 13e-4(i) (Cross-Border Issuer Tender Offer)

☐ Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)

**SCHEDULE TO**

This Amendment No. 2 (this "***Amendment No. 2***") amends and supplements the Tender Offer Statement on Schedule TO originally filed with the Securities and Exchange Commission on January 27, 2023, as amended and supplemented by Amendment No. 1 ("***Amendment No. 1***") to the Tender Offer Statement on Schedule TO filed with the Commission on February 3, 2023 (as it may be further amended or supplemented from time to time, the "***Schedule TO***"), related to the offer by Avantax, Inc., a Delaware corporation formerly known as Blucora, Inc. (the "***Company***"), to purchase for cash up to $250,000,000 of its common stock, par value $0.0001 per share (the "***shares***"), at a price per share of not less than $27.00 and not more than $31.00 in cash, without interest and subject to any applicable withholding taxes. The Company's offer is made upon the terms and subject to the conditions described in the Offer to Purchase, dated January 27, 2023 (as amended or supplemented from time to time, the "***Offer to Purchase***"), a copy of which was filed as Exhibit (a)(1)(i) to the Schedule TO, and in the accompanying Letter of Transmittal (as amended or supplemented from time to time, the "***Letter of Transmittal***" and, together with the Offer to Purchase, the "***tender offer***"), a copy of which was attached as Exhibit (a)(1)(ii) to the Schedule TO.

Except as specifically provided herein, the information contained in the Schedule TO remains unchanged and this Amendment No. 2 does not modify any of the information previously reported on the Schedule TO. You should read this Amendment No. 2 together with the Schedule TO and the tender offer.

<u>Amendments to Exhibit (a)(1)(i)</u>

**I** **tem 7. Source and Amount of Funds or other Consideration.**

The information set forth in Item 7 is hereby amended and supplemented by the following:

(1) The Offer to Purchase is hereby amended and supplemented to add the following two paragraphs following the first paragraph on
 page 29 of the Offer to Purchase as amended by Amendment No. 1:

"We do not have any current plans to refinance any indebtedness under the Delayed Draw Term Loan Facility incurred to finance the purchase of the shares, but we plan to regularly consider whether to refinance such indebtedness based on our results of operations, financial condition, liquidity and prevailing market conditions.

There is no financing condition to the tender offer, although the tender offer is subject to certain other conditions. See Section 7."

**Item 11. Additional Information.**

The information set forth in Item 11 is hereby amended and supplemented by the following:

(1) The first sentence on page 10 of the Offer to Purchase as amended by Amendment No. 1 is hereby deleted in its entirety and replaced
with the following:

"This Offer to Purchase and the documents incorporated by reference into this Offer to Purchase contain certain forward-looking statements."

**SIGNATURES**

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 9, 2023

---

| | |
|:---|:---|
| **AVANTAX, INC.** | **AVANTAX, INC.** |
| By: | /s/ Tabitha Bailey |
| Name: Tabitha Bailey | Name: Tabitha Bailey |
| Title: Chief Legal Officer and Corporate Secretary | Title: Chief Legal Officer and Corporate Secretary |

---

## Corresp

---

| | |
|:---|:---|
| ![](avta-corresp_img001.jpg) | SIDLEY AUSTIN LLP<br> 787 SEVENTH AVENUE<br> NEW YORK, NY 10019<br> +1 212 839 5300<br> +1 212 839 5599 FAX <br>AMERICA • ASIA PACIFIC • EUROPE |

---

February 9, 2023

<u>Via EDGAR and Email</u>

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Mergers & Acquisitions

100 F Street, N.E.

Washington, D.C. 20549

Attention: Mr. Michael Killoy and Christina Chalk

---

| | |
|:---|:---|
| Re: | Avantax, Inc.<br> **Amended Schedule TO-I filed on February 3, 2023<br> File No. 005-55807** |

---

Ladies and Gentlemen:

On behalf of our client, Avantax, Inc. (the "***Company***"), we hereby acknowledge receipt of the comment letter dated February 7, 2023 (the "***Comment Letter***") from the staff (the "***Staff***") of the U.S. Securities and Exchange Commission concerning the above captioned Amended Schedule TO-I (the "***Amended Schedule TO-I***"), which amends and supplements the Schedule TO-I filed on January 27, 2023 (the "***Schedule TO-I***").

We submit this letter in response to the Comment Letter on behalf of the Company. For ease of reference, we have reproduced the text of the Staff's comment in bold-face type below, followed by the Company's response. Unless otherwise noted, page number references herein refer to Exhibit (a)(1)(i) to the Schedule TO-I, which is the Offer to Purchase.

The Company has today filed, via EDGAR, an additional amendment to the Amended Schedule TO-I together with this response letter.

**<u>Responses to Staff Comments on Amended Schedule TO-I</u>**

<u>Cautionary Note Regarding Forward-Looking Statements, page 10</u>

&nbsp;&nbsp;&nbsp;&nbsp;**1.** **We note your response to comment 1 and reissue. The revised disclosure continues to imply that forward-looking statements are subject to the protections of Section 27(A) of the Securities Act and Section 21(E) of the Exchange Act. Please delete the reference to the PSLRA to remove this implication. See Section 27A(b)(2)(c) of the Exchange Act and Section 21E(b)(2)(c) of the Securities and Exchange Act. See also, Question 117.05 of the Going Private Transactions, Exchange Act Rule 13e-3 and Schedule 13E-3 Compliance and Disclosure Interpretations (January 26, 2009) available at www.sec.gov.**![](avta-corresp_img001.jpg)

Securities and Exchange Commission

Division of Corporation Finance

Office of Mergers and Acquisitions

February 9, 2023

*Response*: In response to the Staff's comment, the Company will amend the disclosure on page 10 of the Offer to Purchase by replacing the first sentence on page 10 with the following:

"This Offer to Purchase and the documents incorporated by reference into this Offer to Purchase contain certain forward-looking statements."

<u>Source and Amount of Funds, page 28</u>

&nbsp;&nbsp;&nbsp;&nbsp;**2.** We note your response to comment 3 and reissue. Please disclose the plans or arrangements to repay the
funds used under the Delayed Draw Term Loan Facility to purchase tendered shares, or if no plans or arrangements have been made, please
state. See Item 7 of Schedule TO and Item 1007(d)(2) of Regulation M-A.

*Response*: In response to the Staff's comment, the Company will amend and supplement the disclosure starting on page 28 of the Offer to Purchase by adding the following two paragraphs following the first paragraph on page 29 of the Offer to Purchase as amended by the Amended Schedule TO-I:

"We do not have any current plans to refinance any indebtedness under the Delayed Draw Term Loan Facility incurred to finance the purchase of the shares, but we plan to regularly consider whether to refinance such indebtedness based on our results of operations, financial condition, liquidity and prevailing market conditions.

There is no financing condition to the tender offer, although the tender offer is subject to certain other conditions. See Section 7."

\* \* \*

![](avta-corresp_img001.jpg)

Securities and Exchange Commission

Division of Corporation Finance

Office of Mergers and Acquisitions

February 9, 2023

The Company acknowledges that the Staff may have additional comments after reviewing this response letter.

We appreciate your assistance in reviewing this response letter. Please direct any questions or comments regarding this filing to me at (312) 853-7443 or bberg@sidley.com.

---

| |
|:---|
| Sincerely, |
| /s/ Beth E. Berg |
| Beth E. Berg, Esq. |
| Sidley Austin LLP |

---

cc: Robert Mandell, Esq.<br> Sidley Austin LLP